nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—BCHE—Cisplatin—esophageal cancer	0.292	1	CbGbCtD
Rivastigmine—BCHE—diaphragm—esophageal cancer	0.00801	0.615	CbGeAlD
Rivastigmine—Neostigmine—ABCB1—esophageal cancer	0.00206	1	CrCbGaD
Rivastigmine—Nasopharyngitis—Capecitabine—esophageal cancer	0.00099	0.00187	CcSEcCtD
Rivastigmine—Sepsis—Methotrexate—esophageal cancer	0.000985	0.00186	CcSEcCtD
Rivastigmine—Gastritis—Capecitabine—esophageal cancer	0.000979	0.00185	CcSEcCtD
Rivastigmine—Muscular weakness—Capecitabine—esophageal cancer	0.000976	0.00184	CcSEcCtD
Rivastigmine—Eye disorder—Cisplatin—esophageal cancer	0.000971	0.00183	CcSEcCtD
Rivastigmine—Tinnitus—Cisplatin—esophageal cancer	0.000968	0.00183	CcSEcCtD
Rivastigmine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000965	0.00182	CcSEcCtD
Rivastigmine—Flushing—Cisplatin—esophageal cancer	0.000964	0.00182	CcSEcCtD
Rivastigmine—Cardiac disorder—Cisplatin—esophageal cancer	0.000964	0.00182	CcSEcCtD
Rivastigmine—Dysphagia—Capecitabine—esophageal cancer	0.000956	0.0018	CcSEcCtD
Rivastigmine—Thrombophlebitis—Methotrexate—esophageal cancer	0.000952	0.00179	CcSEcCtD
Rivastigmine—Diabetes mellitus—Methotrexate—esophageal cancer	0.000947	0.00179	CcSEcCtD
Rivastigmine—Bronchospasm—Capecitabine—esophageal cancer	0.000941	0.00177	CcSEcCtD
Rivastigmine—Polyuria—Methotrexate—esophageal cancer	0.000938	0.00177	CcSEcCtD
Rivastigmine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000936	0.00176	CcSEcCtD
Rivastigmine—Sweating increased—Capecitabine—esophageal cancer	0.000932	0.00176	CcSEcCtD
Rivastigmine—Angina pectoris—Capecitabine—esophageal cancer	0.000932	0.00176	CcSEcCtD
Rivastigmine—Arrhythmia—Cisplatin—esophageal cancer	0.000928	0.00175	CcSEcCtD
Rivastigmine—Bronchitis—Capecitabine—esophageal cancer	0.00092	0.00173	CcSEcCtD
Rivastigmine—Alopecia—Cisplatin—esophageal cancer	0.000918	0.00173	CcSEcCtD
Rivastigmine—Malnutrition—Cisplatin—esophageal cancer	0.000904	0.0017	CcSEcCtD
Rivastigmine—Erythema—Cisplatin—esophageal cancer	0.000904	0.0017	CcSEcCtD
Rivastigmine—Dysuria—Capecitabine—esophageal cancer	0.000894	0.00169	CcSEcCtD
Rivastigmine—Renal failure acute—Methotrexate—esophageal cancer	0.000892	0.00168	CcSEcCtD
Rivastigmine—Flatulence—Cisplatin—esophageal cancer	0.000891	0.00168	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000889	0.00168	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000873	0.00165	CcSEcCtD
Rivastigmine—Weight increased—Capecitabine—esophageal cancer	0.00087	0.00164	CcSEcCtD
Rivastigmine—Muscle spasms—Cisplatin—esophageal cancer	0.000869	0.00164	CcSEcCtD
Rivastigmine—Weight decreased—Capecitabine—esophageal cancer	0.000865	0.00163	CcSEcCtD
Rivastigmine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000863	0.00163	CcSEcCtD
Rivastigmine—Pneumonia—Capecitabine—esophageal cancer	0.000858	0.00162	CcSEcCtD
Rivastigmine—Infestation NOS—Capecitabine—esophageal cancer	0.000853	0.00161	CcSEcCtD
Rivastigmine—Infestation—Capecitabine—esophageal cancer	0.000853	0.00161	CcSEcCtD
Rivastigmine—Vision blurred—Cisplatin—esophageal cancer	0.000852	0.00161	CcSEcCtD
Rivastigmine—Depression—Capecitabine—esophageal cancer	0.00085	0.0016	CcSEcCtD
Rivastigmine—Tremor—Cisplatin—esophageal cancer	0.000847	0.0016	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000845	0.00159	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000841	0.00158	CcSEcCtD
Rivastigmine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000841	0.00158	CcSEcCtD
Rivastigmine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000839	0.00158	CcSEcCtD
Rivastigmine—Renal failure—Capecitabine—esophageal cancer	0.000838	0.00158	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000836	0.00158	CcSEcCtD
Rivastigmine—Myocardial infarction—Capecitabine—esophageal cancer	0.000836	0.00158	CcSEcCtD
Rivastigmine—Anaemia—Cisplatin—esophageal cancer	0.000836	0.00158	CcSEcCtD
Rivastigmine—Conjunctivitis—Capecitabine—esophageal cancer	0.000829	0.00156	CcSEcCtD
Rivastigmine—Urinary tract infection—Capecitabine—esophageal cancer	0.000829	0.00156	CcSEcCtD
Rivastigmine—Osteoarthritis—Methotrexate—esophageal cancer	0.000824	0.00155	CcSEcCtD
Rivastigmine—Malaise—Cisplatin—esophageal cancer	0.000815	0.00154	CcSEcCtD
Rivastigmine—Haematuria—Capecitabine—esophageal cancer	0.000813	0.00153	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000806	0.00152	CcSEcCtD
Rivastigmine—Epistaxis—Capecitabine—esophageal cancer	0.000804	0.00152	CcSEcCtD
Rivastigmine—Convulsion—Cisplatin—esophageal cancer	0.000783	0.00148	CcSEcCtD
Rivastigmine—Mood swings—Methotrexate—esophageal cancer	0.00078	0.00147	CcSEcCtD
Rivastigmine—Bradycardia—Capecitabine—esophageal cancer	0.000779	0.00147	CcSEcCtD
Rivastigmine—Ataxia—Methotrexate—esophageal cancer	0.000775	0.00146	CcSEcCtD
Rivastigmine—Myalgia—Cisplatin—esophageal cancer	0.00077	0.00145	CcSEcCtD
Rivastigmine—Haemoglobin—Capecitabine—esophageal cancer	0.000769	0.00145	CcSEcCtD
Rivastigmine—Rhinitis—Capecitabine—esophageal cancer	0.000767	0.00145	CcSEcCtD
Rivastigmine—Anxiety—Cisplatin—esophageal cancer	0.000767	0.00145	CcSEcCtD
Rivastigmine—Haemorrhage—Capecitabine—esophageal cancer	0.000766	0.00144	CcSEcCtD
Rivastigmine—Hepatitis—Capecitabine—esophageal cancer	0.000766	0.00144	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000764	0.00144	CcSEcCtD
Rivastigmine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000762	0.00144	CcSEcCtD
Rivastigmine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000761	0.00143	CcSEcCtD
Rivastigmine—Discomfort—Cisplatin—esophageal cancer	0.00076	0.00143	CcSEcCtD
Rivastigmine—Pharyngitis—Capecitabine—esophageal cancer	0.00076	0.00143	CcSEcCtD
Rivastigmine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000756	0.00143	CcSEcCtD
Rivastigmine—Oedema peripheral—Capecitabine—esophageal cancer	0.000754	0.00142	CcSEcCtD
Rivastigmine—BCHE—bronchus—esophageal cancer	0.000753	0.0578	CbGeAlD
Rivastigmine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000752	0.00142	CcSEcCtD
Rivastigmine—Urethral disorder—Capecitabine—esophageal cancer	0.00075	0.00141	CcSEcCtD
Rivastigmine—Breast disorder—Methotrexate—esophageal cancer	0.000744	0.0014	CcSEcCtD
Rivastigmine—Oedema—Cisplatin—esophageal cancer	0.000738	0.00139	CcSEcCtD
Rivastigmine—Visual impairment—Capecitabine—esophageal cancer	0.000738	0.00139	CcSEcCtD
Rivastigmine—BCHE—smooth muscle tissue—esophageal cancer	0.000737	0.0565	CbGeAlD
Rivastigmine—Infection—Cisplatin—esophageal cancer	0.000733	0.00138	CcSEcCtD
Rivastigmine—Erythema multiforme—Capecitabine—esophageal cancer	0.000724	0.00136	CcSEcCtD
Rivastigmine—Nervous system disorder—Cisplatin—esophageal cancer	0.000724	0.00136	CcSEcCtD
Rivastigmine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000722	0.00136	CcSEcCtD
Rivastigmine—Tachycardia—Cisplatin—esophageal cancer	0.00072	0.00136	CcSEcCtD
Rivastigmine—Skin disorder—Cisplatin—esophageal cancer	0.000717	0.00135	CcSEcCtD
Rivastigmine—Eye disorder—Capecitabine—esophageal cancer	0.000715	0.00135	CcSEcCtD
Rivastigmine—Tinnitus—Capecitabine—esophageal cancer	0.000714	0.00135	CcSEcCtD
Rivastigmine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000713	0.00134	CcSEcCtD
Rivastigmine—Flushing—Capecitabine—esophageal cancer	0.00071	0.00134	CcSEcCtD
Rivastigmine—Cardiac disorder—Capecitabine—esophageal cancer	0.00071	0.00134	CcSEcCtD
Rivastigmine—Anorexia—Cisplatin—esophageal cancer	0.000703	0.00133	CcSEcCtD
Rivastigmine—Pancreatitis—Methotrexate—esophageal cancer	0.000698	0.00132	CcSEcCtD
Rivastigmine—Angiopathy—Capecitabine—esophageal cancer	0.000695	0.00131	CcSEcCtD
Rivastigmine—Mediastinal disorder—Capecitabine—esophageal cancer	0.00069	0.0013	CcSEcCtD
Rivastigmine—Hypotension—Cisplatin—esophageal cancer	0.000689	0.0013	CcSEcCtD
Rivastigmine—Chills—Capecitabine—esophageal cancer	0.000687	0.00129	CcSEcCtD
Rivastigmine—Arrhythmia—Capecitabine—esophageal cancer	0.000684	0.00129	CcSEcCtD
Rivastigmine—Alopecia—Capecitabine—esophageal cancer	0.000676	0.00128	CcSEcCtD
Rivastigmine—BCHE—trachea—esophageal cancer	0.000676	0.0519	CbGeAlD
Rivastigmine—ACHE—lymph node—esophageal cancer	0.000676	0.0519	CbGeAlD
Rivastigmine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000672	0.00127	CcSEcCtD
Rivastigmine—Mental disorder—Capecitabine—esophageal cancer	0.000671	0.00126	CcSEcCtD
Rivastigmine—Erythema—Capecitabine—esophageal cancer	0.000666	0.00126	CcSEcCtD
Rivastigmine—Malnutrition—Capecitabine—esophageal cancer	0.000666	0.00126	CcSEcCtD
Rivastigmine—Dysuria—Methotrexate—esophageal cancer	0.000666	0.00125	CcSEcCtD
Rivastigmine—Paraesthesia—Cisplatin—esophageal cancer	0.000663	0.00125	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000662	0.00125	CcSEcCtD
Rivastigmine—Dyspnoea—Cisplatin—esophageal cancer	0.000658	0.00124	CcSEcCtD
Rivastigmine—Flatulence—Capecitabine—esophageal cancer	0.000657	0.00124	CcSEcCtD
Rivastigmine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000656	0.00124	CcSEcCtD
Rivastigmine—Dysgeusia—Capecitabine—esophageal cancer	0.000653	0.00123	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00065	0.00122	CcSEcCtD
Rivastigmine—Back pain—Capecitabine—esophageal cancer	0.000645	0.00122	CcSEcCtD
Rivastigmine—Decreased appetite—Cisplatin—esophageal cancer	0.000641	0.00121	CcSEcCtD
Rivastigmine—Muscle spasms—Capecitabine—esophageal cancer	0.000641	0.00121	CcSEcCtD
Rivastigmine—Pneumonia—Methotrexate—esophageal cancer	0.000638	0.0012	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000637	0.0012	CcSEcCtD
Rivastigmine—Infestation NOS—Methotrexate—esophageal cancer	0.000635	0.0012	CcSEcCtD
Rivastigmine—Infestation—Methotrexate—esophageal cancer	0.000635	0.0012	CcSEcCtD
Rivastigmine—Drowsiness—Methotrexate—esophageal cancer	0.000635	0.0012	CcSEcCtD
Rivastigmine—Depression—Methotrexate—esophageal cancer	0.000633	0.00119	CcSEcCtD
Rivastigmine—Pain—Cisplatin—esophageal cancer	0.000631	0.00119	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000629	0.00119	CcSEcCtD
Rivastigmine—Vision blurred—Capecitabine—esophageal cancer	0.000628	0.00118	CcSEcCtD
Rivastigmine—Tremor—Capecitabine—esophageal cancer	0.000624	0.00118	CcSEcCtD
Rivastigmine—Renal failure—Methotrexate—esophageal cancer	0.000624	0.00118	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000622	0.00383	CbGpPWpGaD
Rivastigmine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000618	0.00117	CcSEcCtD
Rivastigmine—Conjunctivitis—Methotrexate—esophageal cancer	0.000617	0.00116	CcSEcCtD
Rivastigmine—Anaemia—Capecitabine—esophageal cancer	0.000616	0.00116	CcSEcCtD
Rivastigmine—Sweating—Methotrexate—esophageal cancer	0.000609	0.00115	CcSEcCtD
Rivastigmine—Feeling abnormal—Cisplatin—esophageal cancer	0.000608	0.00115	CcSEcCtD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000608	0.00374	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000606	0.00373	CbGpPWpGaD
Rivastigmine—Haematuria—Methotrexate—esophageal cancer	0.000605	0.00114	CcSEcCtD
Rivastigmine—Malaise—Capecitabine—esophageal cancer	0.000601	0.00113	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.0006	0.00113	CcSEcCtD
Rivastigmine—Epistaxis—Methotrexate—esophageal cancer	0.000599	0.00113	CcSEcCtD
Rivastigmine—Vertigo—Capecitabine—esophageal cancer	0.000599	0.00113	CcSEcCtD
Rivastigmine—Syncope—Capecitabine—esophageal cancer	0.000598	0.00113	CcSEcCtD
Rivastigmine—Palpitations—Capecitabine—esophageal cancer	0.000589	0.00111	CcSEcCtD
Rivastigmine—Loss of consciousness—Capecitabine—esophageal cancer	0.000586	0.0011	CcSEcCtD
Rivastigmine—Body temperature increased—Cisplatin—esophageal cancer	0.000583	0.0011	CcSEcCtD
Rivastigmine—BCHE—digestive system—esophageal cancer	0.000582	0.0446	CbGeAlD
Rivastigmine—Cough—Capecitabine—esophageal cancer	0.000582	0.0011	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000578	0.00356	CbGpPWpGaD
Rivastigmine—Hypertension—Capecitabine—esophageal cancer	0.000575	0.00108	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000575	0.00354	CbGpPWpGaD
Rivastigmine—Haemoglobin—Methotrexate—esophageal cancer	0.000573	0.00108	CcSEcCtD
Rivastigmine—ACHE—ATF-2 transcription factor network—CCND1—esophageal cancer	0.000571	0.00352	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000571	0.00352	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—GNG7—esophageal cancer	0.00057	0.00351	CbGpPWpGaD
Rivastigmine—Haemorrhage—Methotrexate—esophageal cancer	0.00057	0.00107	CcSEcCtD
Rivastigmine—Hepatitis—Methotrexate—esophageal cancer	0.00057	0.00107	CcSEcCtD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000568	0.0035	CbGpPWpGaD
Rivastigmine—Chest pain—Capecitabine—esophageal cancer	0.000567	0.00107	CcSEcCtD
Rivastigmine—Myalgia—Capecitabine—esophageal cancer	0.000567	0.00107	CcSEcCtD
Rivastigmine—Arthralgia—Capecitabine—esophageal cancer	0.000567	0.00107	CcSEcCtD
Rivastigmine—Pharyngitis—Methotrexate—esophageal cancer	0.000566	0.00107	CcSEcCtD
Rivastigmine—Anxiety—Capecitabine—esophageal cancer	0.000565	0.00107	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000564	0.00347	CbGpPWpGaD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000563	0.00106	CcSEcCtD
Rivastigmine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000563	0.00106	CcSEcCtD
Rivastigmine—Discomfort—Capecitabine—esophageal cancer	0.000561	0.00106	CcSEcCtD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00056	0.00345	CbGpPWpGaD
Rivastigmine—Urethral disorder—Methotrexate—esophageal cancer	0.000559	0.00105	CcSEcCtD
Rivastigmine—Dry mouth—Capecitabine—esophageal cancer	0.000555	0.00105	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.00055	0.00339	CbGpPWpGaD
Rivastigmine—Visual impairment—Methotrexate—esophageal cancer	0.000549	0.00104	CcSEcCtD
Rivastigmine—Confusional state—Capecitabine—esophageal cancer	0.000548	0.00103	CcSEcCtD
Rivastigmine—Oedema—Capecitabine—esophageal cancer	0.000544	0.00103	CcSEcCtD
Rivastigmine—Hypersensitivity—Cisplatin—esophageal cancer	0.000544	0.00102	CcSEcCtD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000541	0.00333	CbGpPWpGaD
Rivastigmine—Infection—Capecitabine—esophageal cancer	0.00054	0.00102	CcSEcCtD
Rivastigmine—Erythema multiforme—Methotrexate—esophageal cancer	0.000539	0.00102	CcSEcCtD
Rivastigmine—Shock—Capecitabine—esophageal cancer	0.000535	0.00101	CcSEcCtD
Rivastigmine—ACHE—Neuronal System—ALDH2—esophageal cancer	0.000534	0.00329	CbGpPWpGaD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000534	0.00329	CbGpPWpGaD
Rivastigmine—Nervous system disorder—Capecitabine—esophageal cancer	0.000533	0.00101	CcSEcCtD
Rivastigmine—Eye disorder—Methotrexate—esophageal cancer	0.000533	0.001	CcSEcCtD
Rivastigmine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000533	0.001	CcSEcCtD
Rivastigmine—Tinnitus—Methotrexate—esophageal cancer	0.000531	0.001	CcSEcCtD
Rivastigmine—Tachycardia—Capecitabine—esophageal cancer	0.000531	0.001	CcSEcCtD
Rivastigmine—Asthenia—Cisplatin—esophageal cancer	0.000529	0.000998	CcSEcCtD
Rivastigmine—Cardiac disorder—Methotrexate—esophageal cancer	0.000529	0.000997	CcSEcCtD
Rivastigmine—Skin disorder—Capecitabine—esophageal cancer	0.000528	0.000996	CcSEcCtD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000527	0.00324	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—EP300—esophageal cancer	0.000526	0.00324	CbGpPWpGaD
Rivastigmine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000526	0.000991	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000524	0.00323	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.000522	0.00322	CbGpPWpGaD
Rivastigmine—Anorexia—Capecitabine—esophageal cancer	0.000518	0.000977	CcSEcCtD
Rivastigmine—Angiopathy—Methotrexate—esophageal cancer	0.000517	0.000975	CcSEcCtD
Rivastigmine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000514	0.000968	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000513	0.00316	CbGpPWpGaD
Rivastigmine—Chills—Methotrexate—esophageal cancer	0.000511	0.000964	CcSEcCtD
Rivastigmine—BCHE—Neuronal System—GNG7—esophageal cancer	0.000509	0.00313	CbGpPWpGaD
Rivastigmine—Hypotension—Capecitabine—esophageal cancer	0.000508	0.000958	CcSEcCtD
Rivastigmine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000506	0.00311	CbGpPWpGaD
Rivastigmine—Diarrhoea—Cisplatin—esophageal cancer	0.000505	0.000952	CcSEcCtD
Rivastigmine—Alopecia—Methotrexate—esophageal cancer	0.000504	0.000949	CcSEcCtD
Rivastigmine—Mental disorder—Methotrexate—esophageal cancer	0.000499	0.000941	CcSEcCtD
Rivastigmine—Erythema—Methotrexate—esophageal cancer	0.000496	0.000935	CcSEcCtD
Rivastigmine—Malnutrition—Methotrexate—esophageal cancer	0.000496	0.000935	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000496	0.000934	CcSEcCtD
Rivastigmine—Insomnia—Capecitabine—esophageal cancer	0.000492	0.000927	CcSEcCtD
Rivastigmine—Paraesthesia—Capecitabine—esophageal cancer	0.000488	0.000921	CcSEcCtD
Rivastigmine—BCHE—lung—esophageal cancer	0.000486	0.0373	CbGeAlD
Rivastigmine—Dysgeusia—Methotrexate—esophageal cancer	0.000486	0.000916	CcSEcCtD
Rivastigmine—Dyspnoea—Capecitabine—esophageal cancer	0.000485	0.000914	CcSEcCtD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000482	0.00296	CbGpPWpGaD
Rivastigmine—Back pain—Methotrexate—esophageal cancer	0.00048	0.000905	CcSEcCtD
Rivastigmine—Dyspepsia—Capecitabine—esophageal cancer	0.000479	0.000902	CcSEcCtD
Rivastigmine—BCHE—Neuronal System—ALDH2—esophageal cancer	0.000477	0.00293	CbGpPWpGaD
Rivastigmine—Decreased appetite—Capecitabine—esophageal cancer	0.000473	0.000891	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00047	0.000885	CcSEcCtD
Rivastigmine—Vomiting—Cisplatin—esophageal cancer	0.000469	0.000884	CcSEcCtD
Rivastigmine—Fatigue—Capecitabine—esophageal cancer	0.000469	0.000884	CcSEcCtD
Rivastigmine—Vision blurred—Methotrexate—esophageal cancer	0.000468	0.000881	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000466	0.00287	CbGpPWpGaD
Rivastigmine—Rash—Cisplatin—esophageal cancer	0.000465	0.000877	CcSEcCtD
Rivastigmine—Pain—Capecitabine—esophageal cancer	0.000465	0.000877	CcSEcCtD
Rivastigmine—Constipation—Capecitabine—esophageal cancer	0.000465	0.000877	CcSEcCtD
Rivastigmine—Dermatitis—Cisplatin—esophageal cancer	0.000465	0.000876	CcSEcCtD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000461	0.00284	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00046	0.00283	CbGpPWpGaD
Rivastigmine—Ill-defined disorder—Methotrexate—esophageal cancer	0.00046	0.000868	CcSEcCtD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000459	0.00283	CbGpPWpGaD
Rivastigmine—Anaemia—Methotrexate—esophageal cancer	0.000459	0.000864	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.000458	0.00282	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000455	0.0028	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000452	0.00278	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000452	0.00278	CbGpPWpGaD
Rivastigmine—Feeling abnormal—Capecitabine—esophageal cancer	0.000448	0.000845	CcSEcCtD
Rivastigmine—Malaise—Methotrexate—esophageal cancer	0.000447	0.000843	CcSEcCtD
Rivastigmine—Vertigo—Methotrexate—esophageal cancer	0.000446	0.00084	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000445	0.000838	CcSEcCtD
Rivastigmine—Nausea—Cisplatin—esophageal cancer	0.000438	0.000826	CcSEcCtD
Rivastigmine—Cough—Methotrexate—esophageal cancer	0.000433	0.000816	CcSEcCtD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000433	0.00266	CbGpPWpGaD
Rivastigmine—Urticaria—Capecitabine—esophageal cancer	0.000432	0.000814	CcSEcCtD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000432	0.00266	CbGpPWpGaD
Rivastigmine—Abdominal pain—Capecitabine—esophageal cancer	0.00043	0.00081	CcSEcCtD
Rivastigmine—Body temperature increased—Capecitabine—esophageal cancer	0.00043	0.00081	CcSEcCtD
Rivastigmine—Convulsion—Methotrexate—esophageal cancer	0.00043	0.00081	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000427	0.00263	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.000426	0.00262	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—XBP1—esophageal cancer	0.000423	0.0026	CbGpPWpGaD
Rivastigmine—Arthralgia—Methotrexate—esophageal cancer	0.000422	0.000796	CcSEcCtD
Rivastigmine—Chest pain—Methotrexate—esophageal cancer	0.000422	0.000796	CcSEcCtD
Rivastigmine—Myalgia—Methotrexate—esophageal cancer	0.000422	0.000796	CcSEcCtD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00042	0.00258	CbGpPWpGaD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000419	0.000791	CcSEcCtD
Rivastigmine—Discomfort—Methotrexate—esophageal cancer	0.000417	0.000787	CcSEcCtD
Rivastigmine—Confusional state—Methotrexate—esophageal cancer	0.000408	0.00077	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—SLC30A7—esophageal cancer	0.000405	0.00249	CbGpPWpGaD
Rivastigmine—Infection—Methotrexate—esophageal cancer	0.000402	0.000758	CcSEcCtD
Rivastigmine—Hypersensitivity—Capecitabine—esophageal cancer	0.000401	0.000755	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000397	0.00244	CbGpPWpGaD
Rivastigmine—Nervous system disorder—Methotrexate—esophageal cancer	0.000397	0.000748	CcSEcCtD
Rivastigmine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000396	0.000747	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.000396	0.00244	CbGpPWpGaD
Rivastigmine—Skin disorder—Methotrexate—esophageal cancer	0.000393	0.000741	CcSEcCtD
Rivastigmine—CYP3A4—digestive system—esophageal cancer	0.000392	0.0301	CbGeAlD
Rivastigmine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000391	0.000738	CcSEcCtD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.00039	0.0024	CbGpPWpGaD
Rivastigmine—Asthenia—Capecitabine—esophageal cancer	0.00039	0.000736	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000388	0.00239	CbGpPWpGaD
Rivastigmine—Anorexia—Methotrexate—esophageal cancer	0.000386	0.000727	CcSEcCtD
Rivastigmine—CYP2D6—digestive system—esophageal cancer	0.000385	0.0296	CbGeAlD
Rivastigmine—Pruritus—Capecitabine—esophageal cancer	0.000385	0.000725	CcSEcCtD
Rivastigmine—Hypotension—Methotrexate—esophageal cancer	0.000378	0.000713	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—XBP1—esophageal cancer	0.000377	0.00232	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000373	0.0023	CbGpPWpGaD
Rivastigmine—Diarrhoea—Capecitabine—esophageal cancer	0.000372	0.000701	CcSEcCtD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000371	0.00229	CbGpPWpGaD
Rivastigmine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000369	0.000695	CcSEcCtD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000366	0.00226	CbGpPWpGaD
Rivastigmine—Insomnia—Methotrexate—esophageal cancer	0.000366	0.00069	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000365	0.00225	CbGpPWpGaD
Rivastigmine—Paraesthesia—Methotrexate—esophageal cancer	0.000364	0.000685	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—SLC30A7—esophageal cancer	0.000361	0.00222	CbGpPWpGaD
Rivastigmine—Dyspnoea—Methotrexate—esophageal cancer	0.000361	0.00068	CcSEcCtD
Rivastigmine—Somnolence—Methotrexate—esophageal cancer	0.00036	0.000678	CcSEcCtD
Rivastigmine—Dizziness—Capecitabine—esophageal cancer	0.00036	0.000678	CcSEcCtD
Rivastigmine—Dyspepsia—Methotrexate—esophageal cancer	0.000356	0.000672	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000354	0.00218	CbGpPWpGaD
Rivastigmine—Decreased appetite—Methotrexate—esophageal cancer	0.000352	0.000663	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00035	0.000659	CcSEcCtD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000349	0.00215	CbGpPWpGaD
Rivastigmine—Fatigue—Methotrexate—esophageal cancer	0.000349	0.000658	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000347	0.00213	CbGpPWpGaD
Rivastigmine—Pain—Methotrexate—esophageal cancer	0.000346	0.000653	CcSEcCtD
Rivastigmine—Vomiting—Capecitabine—esophageal cancer	0.000346	0.000652	CcSEcCtD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000345	0.00212	CbGpPWpGaD
Rivastigmine—Rash—Capecitabine—esophageal cancer	0.000343	0.000646	CcSEcCtD
Rivastigmine—Dermatitis—Capecitabine—esophageal cancer	0.000343	0.000646	CcSEcCtD
Rivastigmine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000342	0.0021	CbGpPWpGaD
Rivastigmine—Headache—Capecitabine—esophageal cancer	0.000341	0.000642	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000339	0.00209	CbGpPWpGaD
Rivastigmine—Feeling abnormal—Methotrexate—esophageal cancer	0.000334	0.000629	CcSEcCtD
Rivastigmine—BCHE—lymph node—esophageal cancer	0.000332	0.0255	CbGeAlD
Rivastigmine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000331	0.000624	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000325	0.002	CbGpPWpGaD
Rivastigmine—Nausea—Capecitabine—esophageal cancer	0.000323	0.000609	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000323	0.00199	CbGpPWpGaD
Rivastigmine—Urticaria—Methotrexate—esophageal cancer	0.000322	0.000606	CcSEcCtD
Rivastigmine—Body temperature increased—Methotrexate—esophageal cancer	0.00032	0.000603	CcSEcCtD
Rivastigmine—Abdominal pain—Methotrexate—esophageal cancer	0.00032	0.000603	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000307	0.00189	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000303	0.00187	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000303	0.00187	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000302	0.00186	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000302	0.00186	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—BLVRB—esophageal cancer	0.000301	0.00185	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SLC52A3—esophageal cancer	0.000301	0.00185	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000301	0.00185	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000299	0.00184	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Methotrexate—esophageal cancer	0.000298	0.000562	CcSEcCtD
Rivastigmine—Asthenia—Methotrexate—esophageal cancer	0.00029	0.000548	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000288	0.00177	CbGpPWpGaD
Rivastigmine—Pruritus—Methotrexate—esophageal cancer	0.000286	0.00054	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000283	0.00174	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000278	0.00171	CbGpPWpGaD
Rivastigmine—Diarrhoea—Methotrexate—esophageal cancer	0.000277	0.000522	CcSEcCtD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000275	0.00169	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000269	0.00166	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—BLVRB—esophageal cancer	0.000269	0.00165	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC52A3—esophageal cancer	0.000269	0.00165	CbGpPWpGaD
Rivastigmine—Dizziness—Methotrexate—esophageal cancer	0.000268	0.000505	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.00026	0.0016	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000259	0.00159	CbGpPWpGaD
Rivastigmine—Vomiting—Methotrexate—esophageal cancer	0.000257	0.000485	CcSEcCtD
Rivastigmine—ACHE—Metabolism—SLC10A2—esophageal cancer	0.000256	0.00158	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CA1—esophageal cancer	0.000256	0.00158	CbGpPWpGaD
Rivastigmine—Rash—Methotrexate—esophageal cancer	0.000255	0.000481	CcSEcCtD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000255	0.00157	CbGpPWpGaD
Rivastigmine—Dermatitis—Methotrexate—esophageal cancer	0.000255	0.000481	CcSEcCtD
Rivastigmine—Headache—Methotrexate—esophageal cancer	0.000254	0.000478	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000253	0.00156	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—ACTB—esophageal cancer	0.000251	0.00155	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000247	0.00152	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000245	0.00151	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000241	0.00148	CbGpPWpGaD
Rivastigmine—Nausea—Methotrexate—esophageal cancer	0.00024	0.000453	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00024	0.00148	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CA2—esophageal cancer	0.000234	0.00144	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.00023	0.00142	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000229	0.00141	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC10A2—esophageal cancer	0.000228	0.00141	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CA1—esophageal cancer	0.000228	0.00141	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—HSPA5—esophageal cancer	0.000227	0.0014	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000227	0.0014	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—ACTB—esophageal cancer	0.000224	0.00138	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000223	0.00137	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CALR—esophageal cancer	0.00022	0.00135	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PLCE1—esophageal cancer	0.000218	0.00134	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ADH7—esophageal cancer	0.000218	0.00134	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—GHRL—esophageal cancer	0.000216	0.00133	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000216	0.00133	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000215	0.00132	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—FBXW7—esophageal cancer	0.000213	0.00131	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000211	0.0013	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CA2—esophageal cancer	0.000209	0.00129	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000206	0.00127	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000204	0.00126	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—HSPA5—esophageal cancer	0.000203	0.00125	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000201	0.00124	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000198	0.00122	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CA—esophageal cancer	0.000197	0.00121	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CALR—esophageal cancer	0.000196	0.00121	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ADH7—esophageal cancer	0.000194	0.0012	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PLCE1—esophageal cancer	0.000194	0.0012	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—GHRL—esophageal cancer	0.000193	0.00119	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000192	0.00118	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ADH1B—esophageal cancer	0.000191	0.00118	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—FBXW7—esophageal cancer	0.00019	0.00117	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000188	0.00116	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TYMP—esophageal cancer	0.000182	0.00112	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000179	0.0011	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP26A1—esophageal cancer	0.000178	0.00109	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CA—esophageal cancer	0.000176	0.00108	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000175	0.00108	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALOX15—esophageal cancer	0.000173	0.00106	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ADH1B—esophageal cancer	0.00017	0.00105	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTO1—esophageal cancer	0.000165	0.00102	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TPI1—esophageal cancer	0.000165	0.00102	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TYMP—esophageal cancer	0.000163	0.001	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.00016	0.000984	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP26A1—esophageal cancer	0.000158	0.000975	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALDOB—esophageal cancer	0.000158	0.000974	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000158	0.000971	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALOX15—esophageal cancer	0.000154	0.00095	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GAPDH—esophageal cancer	0.000152	0.000938	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000152	0.000936	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CRABP1—esophageal cancer	0.000151	0.000929	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.00015	0.000925	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000148	0.000913	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTO1—esophageal cancer	0.000147	0.000906	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TPI1—esophageal cancer	0.000147	0.000906	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000147	0.000905	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GNG7—esophageal cancer	0.000144	0.000884	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALDOB—esophageal cancer	0.000141	0.000869	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GAPDH—esophageal cancer	0.000136	0.000836	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CRABP1—esophageal cancer	0.000135	0.000829	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALDH2—esophageal cancer	0.000135	0.000828	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GNG7—esophageal cancer	0.000128	0.000788	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTT1—esophageal cancer	0.000128	0.000788	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP2A6—esophageal cancer	0.000126	0.000779	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000126	0.000776	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000124	0.00076	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000124	0.00076	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALDH2—esophageal cancer	0.00012	0.000739	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ENO1—esophageal cancer	0.00012	0.000738	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS1—esophageal cancer	0.00012	0.000738	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PSME1—esophageal cancer	0.000118	0.000727	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PSME2—esophageal cancer	0.000118	0.000727	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTT1—esophageal cancer	0.000114	0.000703	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP2A6—esophageal cancer	0.000113	0.000695	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000112	0.000692	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS1—esophageal cancer	0.000107	0.000658	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ENO1—esophageal cancer	0.000107	0.000658	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PSME1—esophageal cancer	0.000105	0.000649	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PSME2—esophageal cancer	0.000105	0.000649	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CA1—esophageal cancer	0.000105	0.000647	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000105	0.000647	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000103	0.000635	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP1B1—esophageal cancer	0.000102	0.000628	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CA2—esophageal cancer	9.61e-05	0.000591	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP19A1—esophageal cancer	9.59e-05	0.00059	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.21e-05	0.000567	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP1B1—esophageal cancer	9.1e-05	0.00056	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PLCE1—esophageal cancer	8.93e-05	0.00055	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ADH7—esophageal cancer	8.93e-05	0.00055	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HMOX1—esophageal cancer	8.75e-05	0.000538	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.58e-05	0.000528	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP19A1—esophageal cancer	8.55e-05	0.000526	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ABCB1—esophageal cancer	8.4e-05	0.000517	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—BLVRB—esophageal cancer	8.08e-05	0.000497	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	8.08e-05	0.000497	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ADH1B—esophageal cancer	7.83e-05	0.000482	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HMOX1—esophageal cancer	7.8e-05	0.00048	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.66e-05	0.000471	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ABCB1—esophageal cancer	7.49e-05	0.000461	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TYMP—esophageal cancer	7.49e-05	0.000461	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	7.28e-05	0.000448	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALOX15—esophageal cancer	7.1e-05	0.000437	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CA1—esophageal cancer	6.87e-05	0.000423	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	6.87e-05	0.000423	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TPI1—esophageal cancer	6.77e-05	0.000417	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTO1—esophageal cancer	6.77e-05	0.000417	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALDOB—esophageal cancer	6.49e-05	0.000399	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.35e-05	0.000391	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CA2—esophageal cancer	6.28e-05	0.000387	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GAPDH—esophageal cancer	6.25e-05	0.000385	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CRABP1—esophageal cancer	6.19e-05	0.000381	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GNG7—esophageal cancer	5.89e-05	0.000362	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PLCE1—esophageal cancer	5.84e-05	0.000359	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ADH7—esophageal cancer	5.84e-05	0.000359	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.66e-05	0.000349	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CREBBP—esophageal cancer	5.61e-05	0.000345	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALDH2—esophageal cancer	5.52e-05	0.00034	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTT1—esophageal cancer	5.25e-05	0.000323	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	5.19e-05	0.000319	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ADH1B—esophageal cancer	5.12e-05	0.000315	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NOS3—esophageal cancer	5.02e-05	0.000309	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CREBBP—esophageal cancer	5.01e-05	0.000308	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS1—esophageal cancer	4.92e-05	0.000303	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ENO1—esophageal cancer	4.92e-05	0.000303	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TYMP—esophageal cancer	4.89e-05	0.000301	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PSME2—esophageal cancer	4.85e-05	0.000298	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PSME1—esophageal cancer	4.85e-05	0.000298	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.76e-05	0.000293	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALOX15—esophageal cancer	4.64e-05	0.000286	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS2—esophageal cancer	4.6e-05	0.000283	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NOS3—esophageal cancer	4.48e-05	0.000276	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.43e-05	0.000272	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TPI1—esophageal cancer	4.43e-05	0.000272	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALDOB—esophageal cancer	4.24e-05	0.000261	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	4.18e-05	0.000257	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS2—esophageal cancer	4.1e-05	0.000252	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.08e-05	0.000251	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.05e-05	0.000249	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	3.93e-05	0.000242	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GNG7—esophageal cancer	3.85e-05	0.000237	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—EP300—esophageal cancer	3.82e-05	0.000235	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.61e-05	0.000222	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HMOX1—esophageal cancer	3.59e-05	0.000221	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ABCB1—esophageal cancer	3.44e-05	0.000212	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.43e-05	0.000211	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—EP300—esophageal cancer	3.41e-05	0.00021	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.39e-05	0.000209	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ENO1—esophageal cancer	3.22e-05	0.000198	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.22e-05	0.000198	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PSME2—esophageal cancer	3.17e-05	0.000195	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PSME1—esophageal cancer	3.17e-05	0.000195	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CA—esophageal cancer	2.83e-05	0.000174	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.73e-05	0.000168	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.57e-05	0.000158	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CA—esophageal cancer	2.52e-05	0.000155	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.35e-05	0.000144	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.3e-05	0.000142	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.25e-05	0.000139	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NOS3—esophageal cancer	2.06e-05	0.000127	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.88e-05	0.000116	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—EP300—esophageal cancer	1.57e-05	9.65e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.5e-05	9.26e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.35e-05	8.29e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.23e-05	7.59e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.16e-05	7.14e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—EP300—esophageal cancer	1.02e-05	6.31e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	7.58e-06	4.67e-05	CbGpPWpGaD
